OxyContin's Dark Approval
The journey of OxyContin's approval reveals a troubling connection between the FDA and Purdue Pharma. A single individual, Curtis, initially resisted the drug's approval, labeling it as dangerously addictive. However, after a mysterious meeting, he signed off on the drug with vague language about its addictive properties, paving the way for a financial windfall for the Sackler family. The implications of this decision continue to resonate, highlighting the ethical dilemmas within pharmaceutical approvals.In this clip
From this podcast
Shawn Ryan Show
Peter Berg - Exposing Big Pharma, Lone Survivor, and Hollywood’s Dark Side | SRS #157
Related Questions